Biography

Mark Chapman
Senior Associate

M.Bioc (Oxon), Chartered Patent Attorney, European Patent Attorney

Mark studied Molecular and Cellular Biochemistry at Oxford University (Brasenose College), graduating in 2001 with a first class degree.

He qualified as a Chartered Patent Attorney and European Patent Attorney in 2005. He deals almost exclusively with biotechnological subject-matter, and has experience in a broad range of biotechnologies. He has a particularly detailed knowledge of drafting and prosecution of patent applications concerning viral expression vectors, monoclonal antibody therapeutics, DNA microarrays, cell culture media and systems, molecular and cellular in vitro evolution, gene cloning, stem cells (including both adult adipose and human embryonic stem cells), antisense therapeutics, protein structure determination and bioinformatics.

Mark has extensive experience of both pre-grant (examination) and post-grant (opposition and appeal) proceedings before the European Patent Office, including representing clients at inter partes oral hearings and the preparation and use of experimental data as evidence. Mark also has experience of managing global portfolios of patent applications. He therefore has a working knowledge of patentability requirements and procedures outside Europe, including those in Australia, Canada, Eurasia, China, Israel, Japan, Korea and the United States.